2'-脱氧胸苷-5'-三磷酸三钠,二水结构式
|
常用名 | 2'-脱氧胸苷-5'-三磷酸三钠,二水 | 英文名 | Deoxythymidine triphosphate |
---|---|---|---|---|
CAS号 | 18423-43-3 | 分子量 | 583.12 | |
密度 | 1.922g/cm3 | 沸点 | N/A | |
分子式 | C10H13N2O14P3Na3·2H2O | 熔点 | N/A | |
MSDS | 美版 | 闪点 | N/A |
中文名 | 2’-脱氧胸苷 5’-三磷酸 |
---|---|
英文名 | Thymidine 5'-Triphosphate Sodium Salt |
中文别名 | 三磷酸脱氧胸苷 | 2'-脱氧胸苷-5'-三磷酸钠盐 | 2'-脱氧胸苷-5'-三磷酸钠盐 | 2'-脱氧胸苷-5'-三磷酸三钠,二水 | 胞苷-5-三磷酸钠盐 | 2'-脱氧胸苷-5'-三磷酸三钠盐,二水合物 | 2`-脱氧肌苷 | 2′-脱氧胸苷-5′-三磷酸三钠盐 | 2`-脱氧胸苷-5`三磷酸钠盐 | 2'-脱氧胸苷 5'-三磷酸 | 5'-三磷酸-2--脱氧胸苷三钠盐 | 2'-脱氧胸苷5'-三磷酸 |
英文别名 | 更多 |
密度 | 1.922g/cm3 |
---|---|
分子式 | C10H13N2O14P3Na3·2H2O |
分子量 | 583.12 |
PSA | 282.06000 |
LogP | 0.15130 |
外观性状 | 白色非晶形的粉末 |
储存条件 | −20°C |
分子结构 | 1、 摩尔折射率:84.71 2、 摩尔体积(m3/mol):253.8 3、 等张比容(90.2K):779.6 4、 表面张力(dyne/cm):88.9 5、 极化率(10-24cm3):33.58 |
更多 | 1. 性状:不确定 2. 密度(g/mL,25/4℃):不确定 3. 相对蒸汽密度(g/mL,空气=1):不确定 4. 熔点(ºC):不确定 5. 沸点(ºC,常压):不确定 6. 沸点(ºC, 5.2kPa):不确定 7. 折射率:不确定 8. 闪点(ºC):不确定 9. 比旋光度(º):不确定 10. 自燃点或引燃温度(ºC):不确定 11. 蒸气压(kPa,25ºC):不确定 12. 饱和蒸气压(kPa,60ºC):不确定 13. 燃烧热(KJ/mol):不确定 14. 临界温度(ºC):不确定 15. 临界压力(KPa):不确定 16. 油水(辛醇/水)分配系数的对数值:不确定 17. 爆炸上限(%,V/V):不确定 18. 爆炸下限(%,V/V):不确定 19. 溶解性:不确定 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) | Xi: Irritant; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | S26-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
Am. J. Respir. Crit. Care Med. 191(8) , 943-53, (2015) New regimens to shorten tuberculosis treatment and manage patients with drug-resistant tuberculosis who are infected with HIV are urgently needed. Experimental and clinical evidence suggests that the ... |
|
Evaluation of the systemic innate immune response and metabolic alterations of nonlactating cows with diet-induced subacute ruminal acidosis.
J. Dairy Sci. 97(12) , 7777-87, (2015) Subacute ruminal acidosis (SARA) increases lipopolysaccharide endotoxin in the rumen, which might translocate into the systemic circulation, triggering a cascade of clinical and immunological alterati... |
|
Sputum volume predicts sputum mycobacterial load during the first 2 weeks of antituberculosis treatment.
J. Clin. Microbiol. 53(4) , 1087-91, (2015) Disease severity in patients with pulmonary tuberculosis is associated with mycobacterial sputum load. To ascertain whether reduced sputum production during treatment is a useful clinical sign of impr... |
Deoxythymidine triphosphate |
Thymidine, 5'-(tetrahydrogen triphosphate), sodium salt (1:3) |
2′-deoxythymidine-5′-triphosphate (dTTP) |
2'-Deoxythymidine-5'-Triphosphate sodium salt |
Trisodium 5'-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]thymidine |
MFCD00080338 |
2'-Deoxythymidine-5'-triphosphate (dTTP) |